Susceptibility testing of sequential isolates of Aspergillus fumigatus recovered from treated patients36728

Last updated on 23-8-2019 by Anonymous (non vérifié)

Public Access

Published

Peer reviewed scientific article

SCIENSANO

Résumé:

Two-hundred sequential Aspergillus fumigatus isolates recovered from 26 immunocompromised patients with invasive aspergillosis or bronchial colonization were tested for their in vitro susceptibility to posaconazole, itraconazole, voriconazole, terbinafine and amphotericin B. Twenty-one patients were treated with amphotericin B and/or itraconazole. Antifungal susceptibilities of the isolates recovered before treatment were not significantly different from those of isolates recovered after the onset of antifungal therapy. The highest MICs were 0.125, 0.5, 0.5, 1 and 1 microg ml(-1) for posaco…

Associated health topics:

QR code

QR code for this page URL